MYGN jumps as Myriad agrees to sell Prenatal Health testing business to Labcorp for $210 million cash
Market Chameleon (Tue, 20-Oct 9:52 AM)
Myriad Genetics strikes $210 million prenatal testing divestiture to sharpen focus on cancer care priorities
Market Chameleon (Tue, 20-Oct 9:28 AM)
